Hepatitis C Elimination at the Intersection of People Who Inject Drugs in Rural Settings

Details

to
Virtual

Additional Information

Webinar hosted by the National Institute on Drug Abuse and the Coalition for Global Hepatitis Elimination
Thursday, May 4th | 11am-1pm ET

The next webinar in the "Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination" series will be hosted by the National Institute on Drug Abuse. Speakers will discuss collaborative research on hepatitis C networks among persons who inject drugs, using peers and technology to increase uptake of HCV screening and treatment, and hepatitis C elimination among persons injecting drugs in Mexico during the COVID-19 pandemic.

Presentations will include:

  • Dr. Todd Allen, Professor of Medicine, Harvard Medical School | Collaborative research on Hepatitis C networks among persons who inject drugs using next generation genetic sequencing technology
  • Dr. Todd Korthuis, Professor of Medicine, Oregon Health Sciences University |  Using peers and technology to increase uptake of HCV screening & treatment and substance use disorder treatment among people who use drugs in rural Oregon
  • Dr. Natasha K. Martin, Professor of Medicine, University of California San Diego |  Hepatitis C elimination among people who inject drugs in Mexico during the COVID-19 pandemic

A round-table discussion will follow with comments from:

  • Holly Hagan PhD, MPH; Director, NIDA P30 Center for Drug Use and HIV|HCV Research at Global Public Health; Professor, NYU School of Global Public Health
  • Yngvild K. Olsen MD, MPH; Director of the Center for Substance Abuse Treatment (CSAT); SAMHSA
  • Eyasu Teshale, MD: Division of Viral Hepatitis; CDC
  • Carolyn Wester MD, MPH; Director, Division of Viral Hepatitis; CDC

Past Webinars:

Upcoming Meetings/Events